Carolyn B. Levy

Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site:  Synthesis, In Vitro Characterization, and X-ray Crystallography

Stephen W. Wright, Anthony Carlo, Maynard D. Carty et al. · Journal of Medicinal Chemistry · 2002 · 81 citations · Full text

Drug Target, Bioorganic Chemistry, Novel Allosteric Site +19

Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.

Jeremy C. Parker, R. Kirk McPherson, Kim Andrews et al. · Diabetes · 2000 · 63 citations · Full text

Cellular Pharmacology, Pharmacotherapy, Experimental Pharmacology +17

Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor

W. Ross Tracey, Judith L. Treadway, William P. Magee et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 57 citations

Heart Failure, Cardiovascular Disease, Biochemistry +14

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.

Jeremy C. Parker, Maria A. VanVolkenburg, Carolyn B. Levy et al. · Diabetes · 1998 · 57 citations

Glucose-6-phosphate Translocase, Experimental Pharmacology, Insulin Signaling +19

5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization

Stephen W. Wright, Virginia L. Rath, Paul E. Genereux et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 28 citations · Full text

Medicinal Chemistry, Biochemistry, Natural Sciences +10